Search Count: 15
 |
Erap1 In Complex With 1-[2-(5-Bromo-7-Fluoro-2-Oxo-2,3-Dihydro-1,3-Benzothiazol-3-Yl)Acetamido]-4,4-Difluorocyclohexane-1-Carboxylic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.55 Å Release Date: 2026-05-06 Classification: PEPTIDE BINDING PROTEIN Ligands: ZN, SIN, PO4, EDO, A1JVE |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2026-05-06
Ligands: ZN, SIN, PO4, EDO, A1JVE
 |
Erap1 In Complex With 1-[2-(6-Bromo-2,2-Difluoro-3-Oxo-3,4-Dihydro-2H-1,4-Benzoxazin-4-Yl)Acetamido]Cyclohexane-1-Carboxylic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.57 Å Release Date: 2026-04-22 Classification: PEPTIDE BINDING PROTEIN Ligands: ZN, PO4, EDO, A1JVD |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2026-04-22
Ligands: ZN, PO4, EDO, A1JVD
 |
Erap1 In Complex With 1-[2-(2-Oxo-5-Phenyl-2,3-Dihydro-1,3-Benzoxazol-3-Yl)Acetamido]Cyclohexane-1-Carboxylic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.73 Å Release Date: 2026-04-22 Classification: PEPTIDE BINDING PROTEIN Ligands: ZN, MLT, EDO, A1JVG |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2026-04-22
Ligands: ZN, MLT, EDO, A1JVG
 |
Erap1 In Complex With 1-[2-(5-Chloro-2-Oxo-2,3-Dihydro-1,3-Benzothiazol-3-Yl)Acetamido]Cyclohexane-1-Carboxylic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.45 Å Release Date: 2026-04-22 Classification: PEPTIDE BINDING PROTEIN Ligands: ZN, PO4, EDO, A1JVH |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2026-04-22
Ligands: ZN, PO4, EDO, A1JVH
 |
Erap1 In Complex With 1-[2-(3-Oxo-6-Phenyl-3,4-Dihydro-2H-1,4-Benzoxazin-4-Yl)Acetamido]Cyclohexane-1-Carboxylic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.37 Å Release Date: 2026-04-22 Classification: PEPTIDE BINDING PROTEIN Ligands: ZN, PO4, EDO, A1JVF |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2026-04-22
Ligands: ZN, PO4, EDO, A1JVF
 |
Erap1 In Complex With 1-[2-(3-Oxo-3,4-Dihydro-2H-1,4-Benzothiazin-4-Yl)Acetamido]Cyclohexane-1-Carboxylic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.72 Å Release Date: 2025-01-22 Classification: PEPTIDE BINDING PROTEIN Ligands: ZN, B3P, EDO, BR, A1IMK |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2025-01-22
Ligands: ZN, B3P, EDO, BR, A1IMK
 |
Erap1 In Complex With 1-[2-(6-Bromo-3-Oxo-3,4-Dihydro-2H-1,4-Benzoxazin-4-Yl)Acetamido]-4,4-Difluorocyclohexane-1-Carboxylic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.35 Å Release Date: 2025-01-22 Classification: PEPTIDE BINDING PROTEIN Ligands: ZN, PO4, EDO, A1IMJ |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2025-01-22
Ligands: ZN, PO4, EDO, A1IMJ
 |
Erap1 In Complex With 1-[2-(6-Chloro-3-Oxo-3,4-Dihydro-2H-1,4-Benzothiazin-4-Yl)Acetamido]Cyclohexane-1-Carboxylic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.33 Å Release Date: 2025-01-22 Classification: PEPTIDE BINDING PROTEIN Ligands: ZN, MLT, EDO, A1IMM |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2025-01-22
Ligands: ZN, MLT, EDO, A1IMM
 |
Erap1 In Complex With 1-[2-(2-Oxo-5-Phenyl-2,3-Dihydro-1,3-Benzothiazol-3-Yl)Acetamido]Cyclohexane-1-Carboxylic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.37 Å Release Date: 2025-01-22 Classification: PEPTIDE BINDING PROTEIN Ligands: ZN, PO4, EDO, A1IML |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2025-01-22
Ligands: ZN, PO4, EDO, A1IML
 |
Fak Protac Gsk215 In Complex With Fak And Pvhl:Elonginc:Elonginb
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.24 Å Release Date: 2021-09-29 Classification: TRANSFERASE Ligands: 7QB, PEG, EDO, CA |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-09-29
Ligands: 7QB, PEG, EDO, CA
 |
Human Brd2 C-Terminal Bromodomain With 2-((4-Acetyl-3-Cyclopropyl-3,4-Dihydroquinoxalin-1(2H)-Yl)Methyl)Benzoic Acid
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.76 Å Release Date: 2019-01-30 Classification: TRANSCRIPTION Ligands: PEG, EDO, D7Q |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2019-01-30
Ligands: PEG, EDO, D7Q
 |
Human Brd2 C-Terminal Bromodomain With (S)-5-(1-Acetyl-2-Cyclopropyl-4-(2-(Hydroxymethyl)Benzyl)-1,2,3,4-Tetrahydroquinoxalin-6-Yl)Pyrimidine-2-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.67 Å Release Date: 2019-01-30 Classification: TRANSCRIPTION Ligands: EDO, MES, D7H |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2019-01-30
Ligands: EDO, MES, D7H
 |
Human Brd2 C-Terminal Bromodomain With (S)-1-(2-Cyclopropyl-4-(2-(Hydroxymethyl)Benzyl)-6-(1,2,3,6-Tetrahydropyridin-4-Yl)-3,4-Dihydroquinoxalin-1(2H)-Yl)Ethanone
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.59 Å Release Date: 2019-01-30 Classification: TRANSCRIPTION Ligands: EDO, D7B, PEG, MES |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2019-01-30
Ligands: EDO, D7B, PEG, MES
 |
Bromodomain Of Human Brpf1 With N-1,3-Dimethyl-6-2R-2- Methylpiperazin-1-Yl-2-Oxo-2,3-Dihydro-1H-1,3-Benzodiazol-5-Yl-2- Methoxybenzamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.96 Å Release Date: 2016-07-06 Classification: TRANSCRIPTION Ligands: LF1 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2016-07-06
Ligands: LF1
 |
Bromodomain Of Human Brpf1 With N-1,3-Dimethyl-6-2R-2- Methylpiperazin-1-Yl-2-Oxo-2,3-Dihydro-1H-1,3-Benzodiazol-5-Yl-N- Ethyl-2-Methoxybenzamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2016-07-06 Classification: TRANSCRIPTION Ligands: 8VI, EDO |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2016-07-06
Ligands: 8VI, EDO